Petlife Pharmaceuticals Stock Today
| PTLF Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 44
|
Petlife Pharmaceuticals is trading at 1.0E-4 as of the 18th of April 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Petlife Pharmaceuticals has about a 44 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Petlife Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of September 2022 and ending today, the 18th of April 2024. Click here to learn more.
Petlife Pharmaceuticals, Inc. engages in the research, development, sale, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis in the United States. Petlife Pharmaceuticals, Inc. is based in Los Angeles, California. The company has 196.75 M outstanding shares. More on Petlife Pharmaceuticals
Moving together with Petlife Pink Sheet
| 1.0 | LPCUF | Lees Pharmaceutical | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Petlife Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Petlife Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Petlife Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Laura Leon |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Petlife Pharmaceuticals [PTLF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 393.5 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Petlife Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Petlife Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Petlife Pharmaceuticals conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 196.75 M outstanding shares.
Petlife Pharmaceuticals currently holds about 7.86 K in cash with (318.92 K) of positive cash flow from operations.
Check Petlife Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationPetlife Pharmaceuticals has a total of 196.75 Million outstanding shares. Petlife Pharmaceuticals holds 6.42 pct. of its outstanding shares held by insiders and 0.0 pct. owned by third-party entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Petlife Ownership Details
Petlife Stock Against Markets
Picking the right benchmark for Petlife Pharmaceuticals pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Petlife Pharmaceuticals pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Petlife Pharmaceuticals is critical whether you are bullish or bearish towards Petlife Pharmaceuticals at a given time. Please also check how Petlife Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Petlife Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Petlife Pharmaceuticals Corporate Executives
Elected by the shareholders, the Petlife Pharmaceuticals' board of directors comprises two types of representatives: Petlife Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Petlife. The board's role is to monitor Petlife Pharmaceuticals' management team and ensure that shareholders' interests are well served. Petlife Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Petlife Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
How to buy Petlife Pink Sheet?
Before investing in Petlife Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Petlife Pharmaceuticals. To buy Petlife Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Petlife Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Petlife Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Petlife Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Petlife Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Petlife Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Petlife Pharmaceuticals?
The danger of trading Petlife Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Petlife Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Petlife Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Petlife Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Petlife Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Petlife Pink Sheet analysis
When running Petlife Pharmaceuticals' price analysis, check to measure Petlife Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Petlife Pharmaceuticals is operating at the current time. Most of Petlife Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Petlife Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Petlife Pharmaceuticals' price. Additionally, you may evaluate how the addition of Petlife Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |